Related Experiment Videos
Lymph node histopathologic findings in cutaneous T-cell lymphoma. A prognostic classification system based on
E C Vonderheid1, L W Diamond, S M Lai
1Department of Medicine, Hahnemann University Medical School, Philadelphia, Pennsylvania 19102.
American Journal of Clinical Pathology
|January 1, 1992
Summary
Lymph node involvement in cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome) occurs in 35% of cases. The small cell subtype offers a better prognosis, unlike other subtypes.
Area of Science:
- Oncology
- Dermatology
- Pathology
Background:
- Cutaneous T-cell lymphoma (CTCL), encompassing mycosis fungoides and Sezary syndrome, can involve lymph nodes.
- Lymph node involvement in CTCL is a critical prognostic factor.
- Histopathologic assessment of lymph nodes is essential for staging and prognosis.
Purpose of the Study:
- To retrospectively review the histopathologic features of lymph node involvement in CTCL.
- To classify lymphomatous involvement into subtypes and evaluate their prognostic significance.
- To determine the prognostic impact of dermatopathic lymphadenopathy in CTCL patients.
Main Methods:
- Retrospective analysis of 251 lymph node specimens from 200 patients with CTCL.
- Classification of lymphomatous involvement into four histologic subtypes based on morphology.
- Comparison of survival rates across different subtypes and reactive patterns.
Main Results:
- Lymphomatous involvement was identified in 35% of lymph node specimens.
- Histologic subtypes showed morphologic variability.
- Patients with the small cell (cerebriform) subtype had a significantly better median survival (40 months) compared to other subtypes (20 months).
- Dermatopathic lymphadenopathy had no independent prognostic value.
Conclusions:
- Lymph node involvement in CTCL is common and associated with a poor prognosis.
- The small cell subtype of lymph node involvement in CTCL may represent an earlier, less aggressive stage.
- Histologic subtyping of lymph node involvement aids in prognostic stratification for CTCL patients.